SARS-COV-2 serological studies
The Centre for International Health Protection (ZIG) conducted several SARS-CoV-2 seroprevalence studies worldwide. A cluster-based, risk-stratified sero-epidemiological study on SARS-CoV-2 infections of health care workers was conducted in collaboration with Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) at Kamuzu Central Hospital, Lilongwe, in Malawi. Other sero-epidemiological studies were implemented in Burkina Faso, Ivory Coast, Guinea, Madagascar, Namibia and South Africa.
From May 2021 to December 2022, the study on "Burden of COVID-19 among health care workers, assessing infection, risk factors, working experiences and one-health implications: a mixed methodology, multisite international study" was implemented in Democratic Republic of Congo, Ivory Coast, Madagascar, Nigeria and Germany. The German Federal Ministry of Health funded this study within the Global Health Protection Programme (GHPP).
All studies and protocols were continuously adapted the dynamic situation of the pandemic, e.g. in terms of vaccine deployment.
to the top